LEUKEMIA, MYELOID CHRONIC
Clinical trials for LEUKEMIA, MYELOID CHRONIC explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, MYELOID CHRONIC trials appear
Sign up with your email to follow new studies for LEUKEMIA, MYELOID CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for leukemia patients who failed other therapies
Disease control Recruiting nowThis study tests an experimental pill called HQP1351 in people with chronic myeloid leukemia (CML) or a type of acute lymphoblastic leukemia (Ph+ ALL) that has not responded to at least two prior treatments. The goal is to find the best dose and see how safe and effective the dru…
Matched conditions: LEUKEMIA, MYELOID CHRONIC
Phase: PHASE1 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated May 17, 2026 06:48 UTC
-
New combo strategy aims to deepen remission in CML
Disease control Recruiting nowThis study tests a new drug, asciminib, as the first treatment for adults newly diagnosed with chronic myeloid leukemia (CML). If the drug alone doesn't work well enough after 2-3 years, a low dose of another standard drug is added. The goal is to see if this approach can achieve…
Matched conditions: LEUKEMIA, MYELOID CHRONIC
Phase: PHASE2 • Sponsor: Augusta University • Aim: Disease control
Last updated May 12, 2026 13:40 UTC